Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/24/2007EP1845988A2 Substituted imidazoquinolines and imidazonaphthyridines
10/24/2007EP1845987A2 Treatment of inflammatory disorders with praziquantel
10/24/2007EP1845986A2 Substituted fused [1,2]imidazo[4,5-c]ring compounds and methods
10/24/2007EP1845985A2 Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer
10/24/2007EP1845984A2 Methylphenidate derivatives and uses of them
10/24/2007EP1845983A1 Ophthalmic compositions and methods of using the same
10/24/2007EP1845982A2 Stable oral benzimidazole compositions prepared by non-aqueous layering process
10/24/2007EP1845981A1 Synthesis of sodium narcistatin and related compounds
10/24/2007EP1845980A2 Aqueous gel formulations containing 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine
10/24/2007EP1845979A2 Methods and compositions for decreasing saliva production
10/24/2007EP1845978A1 Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
10/24/2007EP1845977A1 Oral dosage form comprising rosiglitazone
10/24/2007EP1845976A2 Use of inhibitors of soluble epoxide hydrolase to synergize activity of cox and 5-lox inhibitors
10/24/2007EP1845975A1 Combinations of pyrazole kinase inhibitors and further antitumor agents
10/24/2007EP1845974A1 Pharmaceutical compounds
10/24/2007EP1845973A1 Pharmaceutical compounds
10/24/2007EP1845972A2 Novel heteropyrrole analogs acting on cannabiniod receptors
10/24/2007EP1845971A1 A method of treating cellular damage
10/24/2007EP1845969A2 Compositions and methods relating to mitochondrial hyperpolarization in neurological disease
10/24/2007EP1845968A2 Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
10/24/2007EP1845967A2 A method of modulating t cell functioning
10/24/2007EP1845966A1 Antineoplastic preparation and the use of antineoplastic preparation
10/24/2007EP1845965A1 Adapalene for the long-term treatment of acne vulgaris
10/24/2007EP1845964A1 Antimicrobial compositions comprising a natural agent selected from gallic acid, eucalyptol, naringin, a jasmonic acid compound and any combination thereof
10/24/2007EP1845963A2 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma
10/24/2007EP1845962A1 Use of active ingredients containing hydroxystilbene for preventing and/or treating osteoporosis
10/24/2007EP1845961A1 Prevention and treatment of thromboembolic disorders
10/24/2007EP1845957A1 Method for producing a drug extract that contains hydroxystilbene
10/24/2007EP1845955A1 Method for the production of a tamper-proof form of administration
10/24/2007EP1845954A2 Orally disintegrating composition of olanzapine or donepezil
10/24/2007EP1845953A1 Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
10/24/2007EP1845952A2 Stable tablet formulation of tetrahydrobiopterin
10/24/2007EP1845939A1 Drug delivery materials made by sol/gel technology
10/24/2007EP1845938A1 Methods and related compositions for reduction of fat and skin tightening
10/24/2007EP1845935A2 Use of silymarine and/or the constituents thereof as promoters of the pigmentation of the skin or hair
10/24/2007EP1845797A1 Food products comprising hydrolysed milk solids with improved taste
10/24/2007EP1845787A2 Formulations for injection of catecholic butanes, including ndga compounds, into animals
10/24/2007EP1845781A1 Use of compounds derived from pyrimidinetrione as acetyl cholinesterase inhibitors, compositions containing said derivatives, and the uses thereof
10/24/2007EP1845780A2 Uses of methylphenidate derivatives
10/24/2007EP1845779A1 Anti-bacterial compounds
10/24/2007EP1845778A2 Synthesis of inhibitors of p90rsk
10/24/2007EP1845777A2 Starch derivatives and other derivatives, production processes therefor, and wound healing applications therefor
10/24/2007EP1661565B1 Composition comprising l-proline for the treatment of vitiligo
10/24/2007EP1658081B1 Immunosuppressive effects of pteridine derivatives
10/24/2007EP1628647A4 Novel lipids for transfection of nucleic acids
10/24/2007EP1617853B1 Isolation of the hepatoprotective agent acteoside from colerbrokea oppositifolia
10/24/2007EP1606307B1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/24/2007EP1587788B9 2,7-substituted indoles and their use as 5-ht6 modulators
10/24/2007EP1587517B1 Anti-protozoal compositions comprising diclazuril
10/24/2007EP1575590B1 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
10/24/2007EP1562952B1 Method for the catalytic production of hydrocodone and hydromorphone
10/24/2007EP1534710B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/24/2007EP1506041B1 Ibandronic acid for the treatment and prevention of osteoporosis
10/24/2007EP1505980B1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
10/24/2007EP1478401A4 Compositions comprising dietary fat complexer and methods for their use
10/24/2007EP1478343A4 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
10/24/2007EP1471899B1 Use of ambroxol in the treatment of chronic pain
10/24/2007EP1383556B1 INJECTION DEVICE FOR ADMINISTERING mRNA
10/24/2007EP1365771B1 Method of treating certain eye diseases
10/24/2007EP1312366B1 Gelling aqueous pharmaceutical compositions
10/24/2007EP1287006B1 Antitumoral compounds
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007EP1156797B1 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
10/24/2007EP1112743B1 Nitrogenous heterocyclic carboxamide derivatives or salt thereof as antiviral agents
10/24/2007EP0516811B2 Euthanasia compositions
10/24/2007CN101061131A Gemcitabine derivatives nanoparticles
10/24/2007CN101061123A Thienopyridinone compounds and methods of treatment
10/24/2007CN101061122A Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101061120A [3.2.0] heterocyclic compounds and methods of using the same
10/24/2007CN101061119A Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
10/24/2007CN101061118A Substituted bicyclic imidazo-3-ylamine compounds
10/24/2007CN101061116A Sulfonamide compounds
10/24/2007CN101061115A 2-acylaminothiazole derivatives
10/24/2007CN101061114A Amide derivatives, their manufacture and use as pharmaceutical agents
10/24/2007CN101061112A (Spirocyclylamido) aminothiophene compounds as c-Kit proto-oncogene inhibitors
10/24/2007CN101061111A DNA-PK inhibitors
10/24/2007CN101061110A Novel insecticides
10/24/2007CN101061109A Novel pyridonecarboxylic acid derivatives or salts thereof
10/24/2007CN101061108A New 4-benzimidazolyl-3(2h)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer
10/24/2007CN101061107A Amorphous object of cinnamide compound
10/24/2007CN101061106A Potentiators of glutamate receptors
10/24/2007CN101061105A Potentiators of glutamate receptors
10/24/2007CN101061104A Piperidinyl piperidine tachykinin receptor antagonists
10/24/2007CN101061101A Aroylfuranes and aroylthiophenes suitable
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101061097A Novel gamma secretase inhibitors
10/24/2007CN101061094A Piperazine derivatives for alkyloxindoles
10/24/2007CN101061093A Cathepsin cysteine protease inhibitors
10/24/2007CN101061092A Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/24/2007CN101060885A Treating depressive disorders with carbonic anhydrase activators
10/24/2007CN101060863A Modulation of neuroglia-derived BDNF in the treatment and prevention of pain
10/24/2007CN101060862A Composition for oral or rectal administration
10/24/2007CN101060853A Wood hub erythrina arborescens water-alcohol extraction, medicine composition and method for producing these substances
10/24/2007CN101060850A Drugs, food or drink for improving pancreatic functions
10/24/2007CN101060849A Highly branched HK peptides as effective carriers of siRNA
10/24/2007CN101060848A Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone
10/24/2007CN101060847A Loxapine analogs and methods of use thereof
10/24/2007CN101060846A Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
10/24/2007CN101060845A Compounds and methods of treating insulin resistance and cardiomyopathy
1 ... 3534 3535 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 3551 3552 3553 3554 ... 7860